PARSIPPANY, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. PCRX today announced that members of its management team are scheduled to present at the following two healthcare conferences:
- Deutsche Bank 43rd Annual Health Care Conference in Boston, on Wednesday, May 9 at 2:10 PM ET
- Bank of America Merrill Lynch 2018 Healthcare Conference in Las Vegas, on Tuesday, May 15, at 1:40 PM PT (4:40PM ET)
A live audio webcast of the Pacira presentations can be accessed by visiting the "Investors & Media" section of the company's website at investor.pacira.com. A replay of the webcasts will be archived on the Pacira website for two weeks following the presentation dates.
About Pacira
Pacira Pharmaceuticals, Inc. PCRX is a specialty pharmaceutical company dedicated to advancing and improving postsurgical outcomes for acute care practitioners and their patients. The company's flagship product, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.
Company Contact: Pacira Pharmaceuticals, Inc. Christian Pedetti (973) 254-4387 Christian.Pedetti@pacira.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.